Articles, App Notes, Case Studies, & White Papers
-
4 Ways Home Visits Support Successful Rare Disease Clinical Trials
4/25/2023
Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.
-
Safety Monitoring: What Does ePRO Have To Do With It?
1/10/2022
In the available blog post, learn about the importance of safety monitoring in clinical trials.
-
Advancing ALS Research With Digital Health Technologies
5/15/2024
Explore how wearable, sensor-based digital health technologies can revolutionize ALS patient monitoring by reading our latest insights from the Digital Health Monthly scientific webinar series.
-
EHR Integration: Driving Clinical Trial Efficiency
4/21/2025
Explore how clinical trials are integrating Electronic Health Records (EHRs) into trial workflows to better face the increasing demands for efficiency, cost reduction, and improved participant experiences.
-
How Vanguard Clinical Harnesses CDMS/EDC For Faster Results
2/6/2024
Uncover how this CRO was able to stay agile by choosing a CDMS/EDC partner that prioritized sponsor needs and streamlined operations to achieve top-tier results swiftly.
-
What Is Electronic Data Capture And How Does It Simplify Data Management?
5/6/2025
As EDC systems continue to evolve, they streamline workflows, enhance data security, and improve patient outcomes.
-
eConsent: The Missing Ingredient To More Engaging Clinical Trials
8/29/2022
Electronic consent promotes better trial experiences, but many sites and sponsors are wary of giving up paper-based processes. Consider their reasons for caution and how teams can prepare for the switch.
-
Why Prospective Real-World Studies Hold Promise For Research
8/19/2024
Clinical research has always been a cautious and time-consuming affair. Discover how prospective real-world studies are poised to transform the role of RWE in clinical research.
-
Ready For Remote: eCOA Adapts To A Hybrid World
6/2/2022
Due to the global health impact of COVID-19, many aspects of daily life have been moved to a hybrid model, meaning a mix of in-person and technology-enabled interactions In this blog, learn why eCOAs are especially well-suited for hybrid clinical trials.
-
Implementing ICH E6 (R3) In A Risk Averse Culture
11/14/2023
Get several pointers on how to facilitate a transition to an agile, multi-faceted, and continuous risk and issue management approach aligned with the Statistical Analysis Plan.